58.50
-0.34%
Close of 9 Nov 2026, in SAR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Dallah Healthcare Company SJSC
Its shares trade on Tadawul under the ticker 4004.SR. It has been listed since 16 December 2012. In the fiscal year to 31 December 2025, it reported revenue of SAR 4.07bn and net income of SAR 538.0m. At that date it held total assets of SAR 9.14bn and shareholders' equity of SAR 4.08bn.
Dallah Healthcare Co. engages in the provision and operation of healthcare programs and utilities. The company is headquartered in Riyadh, Riyadh. The company went IPO on 2012-12-16. The firm operates in the following business segments: Hospitals; Medicines, and Head Office. The Hospitals’ segment objectives are to own, manage, operate and maintain healthcare facilities. The Medicines’ segment objectives are to import, distribute, wholesale and retail medicines, as well as manufacture medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants, and packaging materials. The Head Office’s segment objectives are to operate, manage and maintain healthcare facilities; wholesale and retail surgical equipment, artificial parts, handicapped and hospitals equipment, as well as other supporting services.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 16 Dec 2012
- Website
- dallahhealth.com/english/home ↗
Leadership
Pay as last reported
- Eng. Tarek Othman AlkasabiNon-Executive Chairman of the BoardSAR 1.8m
- Dr. Ahmad BabaeerChief Executive Officer, since 2016SAR 8,000
- Mr. Mohiuddin Saleh Abdullah KamelNon-Executive Vice Chairman of the Board, since 2022SAR 375,000
- Mr. Amin Bin Abdul Raouf HarizChief Financial Officer
- Eng. Abdulaziz Saleh Al-wahaibiChief Operating Officer
- Eng. Ismail AbdullahChief Digital Transformation Officer
- Dr. Salah Rashid Al-FaqihChief Medical Officer, since 2023
- Mr. Omar Mohammed AljabariChief Commercial Officer- Dallah Health
- Eng. Muteab Abdullah AltukeasChief Strategy Officer - Dallah Health
- Dr. Mohammed Rashid Al-FaqihNon-Executive Non-Independent Member of the Board, since 2023SAR 375,000
- Mr. Fahad Abdullah Al-QassimNon-Executive Non-Independent Member of the Board, since 2019SAR 370,000
- Eng. Mohammed Nabil HefniNon-Executive Non-Independent Member of the BoardSAR 375,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 27
- Environment
- 30
- Social
- 27
- Governance
- 25
- Carbon reduction policy
- No
- Human rights policy
- No
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Dallah Healthcare Company operates multiple hospitals in Riyadh.
- The Medicines segment manufactures pharmaceuticals and herbals locally.
- The firm distributes wholesale and retail medicines widely.
Weaknesses
- The Head Office manages supporting services for hospitals.
- Operations are concentrated in the Riyadh city area.
- The company relies on imported packaging materials.
Opportunities
- The firm can expand its retail medicine sales.
- Manufacturing cosmetics offers growth in the health sector.
- Distributing surgical equipment increases revenue potential significantly.
Threats
- Competition in the Riyadh healthcare market is high.
- Importing medicines exposes the firm to currency risks.
- Regulatory changes affect pharmaceutical manufacturing standards locally.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.